Palisade Bio Inc (PALI)
4.76
+0.15
(+3.25%)
USD |
NASDAQ |
May 31, 16:00
4.81
+0.05
(+1.05%)
After-Hours: 20:00
Palisade Bio 1 Year Total Returns (Daily): -75.96% for May 31, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 31, 2024 | -75.96% |
May 30, 2024 | -76.89% |
May 29, 2024 | -77.73% |
May 28, 2024 | -76.49% |
May 24, 2024 | -77.43% |
May 23, 2024 | -78.09% |
May 22, 2024 | -76.60% |
May 21, 2024 | -75.79% |
May 20, 2024 | -73.83% |
May 17, 2024 | -73.66% |
May 16, 2024 | -73.08% |
May 15, 2024 | -73.25% |
May 14, 2024 | -73.84% |
May 13, 2024 | -73.92% |
May 10, 2024 | -71.87% |
May 09, 2024 | -71.26% |
May 08, 2024 | -71.65% |
May 07, 2024 | -67.08% |
May 06, 2024 | -64.75% |
May 03, 2024 | -68.15% |
May 02, 2024 | -70.18% |
May 01, 2024 | -71.57% |
April 30, 2024 | -74.72% |
April 29, 2024 | -74.09% |
April 26, 2024 | -74.95% |
Date | Value |
---|---|
April 25, 2024 | -73.03% |
April 24, 2024 | -73.37% |
April 23, 2024 | -77.58% |
April 22, 2024 | -81.33% |
April 19, 2024 | -83.21% |
April 18, 2024 | -82.12% |
April 17, 2024 | -77.20% |
April 16, 2024 | -79.19% |
April 15, 2024 | -85.40% |
April 12, 2024 | -86.20% |
April 11, 2024 | -85.76% |
April 10, 2024 | -86.50% |
April 09, 2024 | -82.63% |
April 08, 2024 | -80.67% |
April 05, 2024 | -83.05% |
April 04, 2024 | -81.11% |
April 03, 2024 | -82.79% |
April 02, 2024 | -89.14% |
April 01, 2024 | -88.91% |
March 28, 2024 | -74.90% |
March 27, 2024 | -75.75% |
March 26, 2024 | -77.27% |
March 25, 2024 | -77.88% |
March 22, 2024 | -78.25% |
March 21, 2024 | -78.46% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-98.20%
Minimum
Nov 21 2022
230.1%
Maximum
Mar 23 2021
-65.83%
Average
-87.14%
Median
Nov 13 2023
1 Year Total Returns (Daily) Benchmarks
TG Therapeutics Inc | -38.75% |
Protagenic Therapeutics Inc | -33.67% |
Bio-Path Holdings Inc | -93.64% |
Intra-Cellular Therapies Inc | 13.24% |
Jaguar Health Inc | -89.40% |